NADPH oxidase elevations in pyramidal neurons drive psychosocial stress-induced neuropathology

Translational Psychiatry

Volumn 2, Issue , 2012, Pages

  Schiavone, S ^a   Jaquet, V ^a   Sorce, S ^a   Dubois Dauphin, M ^a   Hultqvist, M ^b   Backdahl L ^c   Holmdahl, R ^c   Colaianna, M ^d   Cuomo, V ^e   Trabace, L ^d   Krause, K H ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b Redoxis AB   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF FOGGIA   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

apocynin; behavior; brain; parvalbumin; psychosis; social isolation

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; APOCYNIN; GLUTAMIC ACID; PARVALBUMIN; PROTEIN P47 PHOX; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; UNCLASSIFIED DRUG; ACETOPHENONE DERIVATIVE; ANTIOXIDANT; CYBB PROTEIN, RAT; MEMBRANE PROTEIN; NEUTROPHIL CYTOSOLIC FACTOR 1;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BEHAVIOR DISORDER; BIOSYNTHESIS; BRAIN NERVE CELL; CELL LEVEL; CONTROLLED STUDY; DIALYSATE LEVEL; DRUG TARGETING; ENZYME ACTIVITY; ENZYME SUBUNIT; EXPERIMENTAL MODEL; GENETIC POLYMORPHISM; LOSS OF FUNCTION MUTATION; MENTAL STRESS; MICROGLIA; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PHAGOCYTE; PROTEIN EXPRESSION; PSYCHOSIS; PYRAMIDAL NERVE CELL; RAT; SIGNAL TRANSDUCTION; SOCIAL ISOLATION; ALLELE; ANIMAL; BRAIN; DISEASE MODEL; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; WISTAR RAT;

ACETOPHENONES; ALLELES; ANIMALS; ANTIOXIDANTS; BRAIN; DISEASE MODELS, ANIMAL; DNA MUTATIONAL ANALYSIS; GLUTAMIC ACID; MEMBRANE GLYCOPROTEINS; NADPH OXIDASE; OXIDATIVE STRESS; PARVALBUMINS; POLYMORPHISM, GENETIC; PSYCHOTIC DISORDERS; PYRAMIDAL CELLS; RATS; RATS, WISTAR; SOCIAL ISOLATION;

EID: 84861148188     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2012.36     Document Type: Article

References (82)

1. van Winkel R, Stefanis N, Myin-Germeys I. Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction. Schizophr Bull 2008;34:1095-1105.
2. Yao J, Ravinder R. Oxidative stress in schizophrenia: pathogenetic and therapeutic implications. Antioxid Redox Signal 2011;15:1999-2002.
3. Bedard K, Krause K. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007;87:245-313. (Pubitemid 46209993)
4. Sorce S, Krause K-H. NOX enzymes in the central nervous system: from signaling to disease. Antioxid Redox Signal 2009;11:2481-2504.
5. Infanger D, Sharma R, Davisson R. NADPH oxidases of the brain: distribution, regulation, and function. Antioxid Redox Signal 2006;8:1583-1596. (Pubitemid 44726333)
6. Bubeníková-Valesová V, Horácek J, Vrajová M, Höschl C. Models of schizophrenia in humans and animals based on inhibition of NMDA receptors. Neurosci Biobehav Rev 2008;32:1014-1023. (Pubitemid 351756510)
7. Sorce S, Schiavone S, Tucci P, Colaianna M, Jaquet V, Cuomo V et al. The NADPH oxidase NOX2 controls glutamate release: a novel mechanism involved in psychosis-like ketamine responses. J Neurosci 2010;30:11317-11325.
8. Behrens M, Ali S, Dao D, Lucero J, Shekhtman G, Quick K et al. Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science 2007;318:1645-1647. (Pubitemid 350233667)
9. Behrens M, Ali S, Dugan L. Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia. J Neurosci 2008;28:13957-13966.
10. Powell SB, Sejnowski TJ, Behrens MM. Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia. Neuropharmacology 2012;62:1322-1331.
11. Weiss I, Feldon J. Environmental animal models for sensorimotor gating deficiencies in schizophrenia: a review. Psychopharmacology (Berl) 2001;156:305-326. (Pubitemid 32702221)
12. Leng A, Feldon J, Ferger B. Long-term social isolation and medial prefrontal cortex: dopaminergic and cholinergic neurotransmission. Pharmacol Biochem Behav 2004;77:371-379. (Pubitemid 38125171)
13. King M, Seeman P, Marsden C, Fone K. Increased dopamine D2High receptors in rats reared in social isolation. Synapse 2009;63:476-483.
14. Geyer MA, Ellenbroek B. Animal behavior models of the mechanisms underlying antipsychotic atypicality. Progr Neuro-Psychopharmacol Biol Psychiatry 2003;27:1071-1079. (Pubitemid 37464953)
15. Lapiz M, Fulford A, Muchimapura S, Mason R, Parker T, Marsden C. Influence of postweaning social isolation in the rat on brain development, conditioned behavior, and neurotransmission. Neurosci Behav Physiol 2003;33:13-29. (Pubitemid 36230868)
16. Harte M, Powell S, Swerdlow N, Geyer M, Reynolds G. Deficits in parvalbumin and calbindin immunoreactive cells in the hippocampus of isolation reared rats. J Neural Transm 2007;114:893-898. (Pubitemid 47013594)
17. Schiavone S, Sorce S, Dubois-Dauphin M, Jaquet V, Colaianna M, Zotti M et al. Involvement of NOX2 in the development of behavioral and pathologic alterations in isolated rats. Biol Psychiatry 2009;66:384-392.
18. Olofsson P, Holmberg J, Tordsson J, Lu S, Akerström B, Holmdahl R. Positional identification of Ncf1 as a gene that regulates arthritis severity in rats. Nat Genet 2003;33:25-32. (Pubitemid 36068678)
19. Olofsson P, Johansson Å, Wedekind D, Klöting I, Klinga-Levan K, Lu S et al. Inconsistent susceptibility to autoimmunity in inbred LEW rats is due to genetic crossbreeding involving segregation of the arthritis-regulating gene Ncf1. Genomics 2004;83:765-771. (Pubitemid 38469919)
20. Hultqvist M, Sareila O, Vilhardt F, Norin U, Olsson L, Olofsson P et al. Positioning of a polymorphic quantitative trait nucleotide in the Ncf1 gene controlling oxidative burst response and arthritis severity in rats. Antioxid Redox Signal 2011;14:2373-2383.
21. Léna I, Chessel A, Le Pen G, Krebs M, Garcia R. Alterations in prefrontal glutamatergic and noradrenergic systems following MK-801 administration in rats prenatally exposed to methylazoxymethanol at gestational day 17. Psychopharmacology (Berl) 2007;192:373-383. (Pubitemid 46701576)
22. da Silva FCC, do Carmo de Oliveira Cito M, da Silva MIG, Moura BA, de Aquino Neto MR, Feitosa ML et al. Behavioral alterations and pro-oxidant effect of a single ketamine administration to mice. Brain Res Bull 2010;83:9-15.
23. Fone KCF, Porkess MV. Behavioural and neurochemical effects of post-weaning social isolation in rodents-relevance to developmental neuropsychiatric disorders. Neurosci Biobehav Rev 2008;32:1087-1102.
24. Zhao X, Sun L, Jia H, Meng Q, Wu S, Li N et al. Isolation rearing induces social and emotional function abnormalities and alters glutamate and neurodevelopment-related gene expression in rats. Progr Neuro-Psychopharmacol Biol Psychiatry 2009;33:1173-1177.
25. Harraz M, Marden J, Zhou W, Zhang Y, Williams A, Sharov V. SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. J Clin Invest 2008;18:659-670. (Pubitemid 351206555)
26. Arakawa H. Age dependent effects of space limitation and social tension on open-field behavior in male rats. Physiol Behav 2005;84:429-436. (Pubitemid 40342597)
27. Carratù M, Borracci P, Coluccia A, Giustino A, Renna G, Tomasini M. Acute exposure to methylmercury at two developmental windows: focus on neurobehavioral and neurochemical effects in rat offspring. Neuroscience 2006;141:1619-1629. (Pubitemid 44128692)
28. Ennaceur A, Delacour J. A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data. Behav Brain Res 1988;31:47-59.
29. King M, Sleight A, Woolley M, Topham I, Marsden C, Fone K. 5-HT6 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing consolidation-an effect sensitive to NMDA receptor antagonism. Neuropharmacology 2004;47:195-204. (Pubitemid 38824643)
30. Trabace L, Cassano T, Colaianna M, Castrignanò S, Giustino A, Amoroso S. Neurochemical and neurobehavioral effects of ganstigmine (CHF2819), a novel acetylcholinesterase inhibitor, in rat prefrontal cortex: an in vivo study. Pharmacol Res 2007;56:288-294. (Pubitemid 47488896)
31. Giovannini M, Bartolini L, Kopf S, Pepeu G. Acetylcholine release from the frontal cortex during exploratory activity. Brain Res 1998;784:218-227. (Pubitemid 28137865)
32. Carli M, Calcagno E, Mainolfi P, Mainini E, Invernizzi R. Effects of aripiprazole, olanzapine, and haloperidol in a model of cognitive deficit of schizophrenia in rats: relationship with glutamate release in the medial prefrontal cortex. Psychopharmacology (Berl) 2011;214:639-652.
33. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. Academic Press: New York, 1986.
34. Czéh B, Perez-Cruz C, Fuchs E, Flügge G. Chronic stress-induced cellular changes in the medial prefrontal cortex and their potential clinical implications: does hemisphere location matter? Behav Brain Res 2008;190:1-13.
35. Uchizono Y, Takeya R, Iwase M, Sasaki N, Oku M, Imoto H et al. Expression of isoforms of NADPH oxidase components in rat pancreatic islets. Life Sci 2006;80:133-139. (Pubitemid 44853977)
36. Alquicer G, Morales-Medina JC, Quirion R, Flores G. Postweaning social isolation enhances morphological changes in the neonatal ventral hippocampal lesion rat model of psychosis. J Chem Neuroanat 2008;35:179-187. (Pubitemid 351221245)
37. Breen A, Murphy J. Reactions of oxyl radicals with DNA. Pharmacol Res 1995;18:1033-1077.
38. Parnavelas J, Lieberman A, Webster K. Organization of neurons in the visual cortex, area 17, of the rat. J Anat 1977;124:305-322. (Pubitemid 8218049)
39. Miller M. Development of projection and local circuit neurons in neocortex. In: Cerebral Cortex. Peters and Jones (eds). vol. 7. Development and maturation of cerebral cortex. Plenum Press: New York, 1988, pp 133-175.
40. Wohleb E, Hanke M, Corona A, Powell N, Stiner L, Bailey M et al. Adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeat. J Neurosci 2011;31:6277-6288.
41. Kern S, Oakes TR, Stone CK, McAuliff EM, Kirschbaum C, Davidson RJ. Glucose metabolic changes in the prefrontal cortex are associated with HPA axis response to a psychosocial stressor. Psychoneuroendocrinology 2008;33:517-529.
42. Oei N, Everaerd W, Elzinga B, van Well S, Bermond B. Psychosocial stress impairs working memory at high loads: an association with cortisol levels and memory retrieval. Stress 2006;9:133-141. (Pubitemid 44581955)
43. Gibb J, Hayley S, Gandhi R, Poulter MO, Anisman H. Synergistic and additive actions of a psychosocial stressor and endotoxin challenge: circulating and brain cytokines, plasma corticosterone and behavioral changes in mice. Brain Behav Immun 2008;22:573-589.
44. Amato J, Bankson M, Yamamoto B. Prior exposure to chronic stress and MDMA potentiates mesoaccumbens dopamine release mediated by the 5-HT (1B) receptor. Neuropsychopharmacology 2007;32:946-954. (Pubitemid 46426178)
45. Perry JC, D'Almeida V, Antunes IB, Tufik S. Distinct behavioral and neurochemical alterations induced by intermittent hypoxia or paradoxical sleep deprivation in rats. Progr Neuro-Psychopharmacol Biol Psychiatry 2008;32:87-94.
46. Lukkes JL, Mokin MV, Scholl JL, Forster GL. Adult rats exposed to early-life social isolation exhibit increased anxiety and conditioned fear behavior, and altered hormonal stress responses. Hormones Behav 2009;55:248-256.
47. Gos T, Becker K, Bock J, Malecki U, Bogerts B, Poeggel G et al. Early neonatal and postweaning social emotional deprivation interferes with the maturation of serotonergic and tyrosine hydroxylase-immunoreactive afferent fiber systems in the rodent nucleus accumbens, hippocampus and amygdala. Neuroscience 2006;140:811-821. (Pubitemid 43786423)
48. Han X, Wang W, Shao F, Li N. Isolation rearing alters social behaviors and monoamine neurotransmission in the medial prefrontal cortex and nucleus accumbens of adult rats. Brain Res 2011;1385:175-181.
49. Fabricius K, Steiniger-Brach B, Helboe L, Fink-Jensen A, Wörtwein G. Socially isolated rats exhibit changes in dopamine homeostasis pertinent to schizophrenia. Int J Dev Neurosci 2011;29:347-350.
50. Do KQ, Cabungcal JH, Frank A, Steullet P, Cuenod M. Redox dysregulation, neurodevelopment, and schizophrenia. Curr Opin Neurobiol 2009;19:220-230.
51. Owe-Larsson B, Ekdahl K, Edbom T, Osby U, Karlsson H, Lundberg C et al. Increased plasma levels of thioredoxin-1 in patients with first episode psychosis and long-term schizophrenia. Progr Neuro-Psychopharmacol Biol Psychiatry 2011;35:1117-1121.
52. Li XF, Zheng YL, Xiu MH, Chen DC, Kosten TR, Zhang XY. Reduced plasma total antioxidant status in first-episode drug-naive patients with schizophrenia. Progr Neuro-Psychopharmacol Biol Psychiatry 2011;35:1064-1067.
53. Karelina K, DeVries A. Modeling social influences on human health. Psychosom Med 2011;73:67-74.
54. Marsden CA, King MV, Fone KCF. Influence of social isolation in the rat on serotonergic function and memory-relevance to models of schizophrenia and the role of 5-HT6 receptors. Neuropharmacology 2011;61:400-407.
55. Bohus B, Benus R, Fokkema D, Koolhaas J, Nyakas C, van Oortmerssen G et al. Neuroendocrine states and behavioral and physiological stress responses. Prog Brain Res 1987;72:57-70.
56. Torrey EF, Yolken RH. The schizophrenia-rheumatoid arthritis connection: infectious, immune, or both? Brain Behav Immunity 2001;15:401-410.
57. Vinogradov S, Gottesman I, Moises H, Nicol S. Negative association between schizophrenia and rheumatoid arthritis. Schizophr Bull 1991;17:669-678.
58. Gorwood P, Pouchot J, Vinceneux P, Puéchal X, Flipo R, De Bandt M et al. Rheumatoid arthritis and schizophrenia: a negative association at a dimensional level. Schizophr Res 2004;66:21-29. (Pubitemid 38030341)
59. Tang LLYK, Yang XF, Zheng JS. Apocynin attenuates cerebral infarction after transient focal ischaemia in rats. J Int Med Res 2007;35:517-522. (Pubitemid 47261114)
60. Wang Q, Tompkins KD, Simonyi A, Korthuis RJ, Sun AY, Sun GY. Apocynin protects against global cerebral ischemia-reperfusion-induced oxidative stress and injury in the gerbil hippocampus. Brain Res 2006;1090:182-189. (Pubitemid 43817927)
61. Lull M, Levesque S, Surace M, Block M. Chronic apocynin treatment attenuates beta amyloid plaque size and microglial number in hAPP (751) (SL) mice. PLoS One 2011;6:e20153.
62. Zeevalk G, Derr-Yellin E, Nicklas W. Relative vulnerability of dopamine and GABA neurons in mesencephalic culture to inhibition of succinate dehydrogenase by malonate and 3-nitropropionic acid and protection by NMDA receptor blockade. J Pharmacol Exp Ther 1995;257:1124-1130. (Pubitemid 26129913)
63. Guentchev M, Voigtländer T, Haberler C, Groschup MH, Budka H. Evidence for oxidative stress in experimental prion disease. Neurobiol Dis 2000;7:270-273.
64. Mei Y, Gawai KR, Nie Z, Ramkumar V, Helfert RH. Age-related reductions in the activities of antioxidant enzymes in the rat inferior colliculus. Hearing Res 1999;135:169-180. (Pubitemid 29397469)
65. Atkins C, Sweatt J. Reactive oxygen species mediate activity-dependent neuron-glia signaling in output fibers of the hippocampus. J Neurosci 1999;19:7241-7248. (Pubitemid 29404580)
66. Tosic M, Ott J, Barral S, Bovet P, Deppen P, Gheorghita F et al. Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene. Am J Hum Genet 2006;79:586-592. (Pubitemid 44384270)
67. Pantano C, Reynaert N, van der Vliet A, Janssen-Heininger Y. Redox-sensitive kinases of the nuclear factor-kappaB signaling pathway. Antioxid Redox Signal 2006;8:1791-1806. (Pubitemid 44726352)
68. Prosser BL, Ward CW, Lederer WJ. X-ROS signaling: rapid mechano-chemo transduction in heart. Science 2011;333:1440-1445.
69. Guidotti A, Auta J, Davis JM, Gerevini VD, Dwivedi Y, Grayson DR et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry 2000;57:1061-1069.
70. Hossein Fatemi S, Stary JM, Earle JA, Araghi-Niknam M, Eagan E. GABAergic dysfunction in schizophrenia and mood disorders as reflected by decreased levels of glutamic acid decarboxylase 65 and 67 kDa and reelin proteins in cerebellum. Schizophr Res 2005;72:109-122. (Pubitemid 39550982)
71. Thompson M, Weickert CS, Wyatt E, Webster MJ. Decreased glutamic acid decarboxylase67 mRNA expression in multiple brain areas of patients with schizophrenia and mood disorders. J Psychiatr Res 2009;43:970-977.
72. Lodge D, Behrens M, Grace AA. A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia. J Neurosci 2009;29:2344-2354.
73. Kilts CD. The changing roles and targets for animal models of schizophrenia. Biol Psychiatry 2001;50:845-855. (Pubitemid 34020698)
74. Kalkman HO, Loetscher E. GAD (67): the link between the GABA-deficit hypothesis and the dopaminergic-and glutamatergic theories of psychosis. J Neural Transm 2003;110:803-812. (Pubitemid 36783233)
75. Turnock-Jones J, Jennings C, Robbins M, Cluderay J, Cilia J, Reid J et al. Increased expression of the NR2A NMDA receptor subunit in the prefrontal cortex of rats reared in isolation. Synapse 2009;63:836-884.
76. Morris R, Anderson E, Lynch G, Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 1986;319:774-776. (Pubitemid 16145031)
77. Steele RJ, Stewart MG, Rose SPR. Increases in NMDA receptor binding are specifically related to memory formation for a passive avoidance task in the chick: a quantitative autoradiographic study. Brain Res 1995;674:352-356.
78. Carmignoto G, Vicini S. Activity-dependent decrease in NMDA receptor responses during development of the visual cortex. Science 1992;258:1007-1011.
79. Ju Kim M, Shin K-S, Chung Y-B, Jung KW, Cha CI, Hoon Shin D. Immunohistochemical study of p47Phox and gp91Phox distributions in rat brain. Brain Res 2005;1040:178-186. (Pubitemid 40459631)
80. Serrano F, Kolluri NS, Wientjes FB, Card JP, Klann E. NADPH oxidase immunoreactivity in the mouse brain. Brain Res 2003;988(1-2):193-198. (Pubitemid 37289510)
81. Yoshioka H, Niizuma K, Katsu M, Okami N, Sakata H, Kim G et al. NADPH oxidase mediates striatal neuronal injury after transient global cerebral ischemia. J Cereb Blood Flow Metab 2011;31:868-880.
82. Carrano A, Hoozemans J, van der Vies S, Rozemuller A, van Horssen J, de Vries H. Amyloid beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy. Antioxid Redox Signal 2011;15:1167-1178.